Brigitte De La Lande

Breast Cancer With Synchronous Metastases: Survival Impact of Exclusive Locoregional Radiotherapy

Romuald Le Scodan, Denise Stevens, Étienne Brain et al. · Journal of Clinical Oncology · 2009 · 165 citations · Full text

Radiotherapy for Stage II and Stage III Breast Cancer Patients With Negative Lymph Nodes After Preoperative Chemotherapy and Mastectomy

Romuald Le Scodan, J. Selz, Denise Stevens et al. · International Journal of Radiation Oncology*Biology*Physics · 2011 · 99 citations

Preoperative Chemotherapy, Surgical Oncology, Breast Oncology +11

A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: Final results

Jacques Rouëssé, Brigitte De La Lande, F. Bertheault-Cvitkovic et al. · International Journal of Radiation Oncology*Biology*Physics · 2006 · 75 citations

Radiation Medicine, Surgical Oncology, Breast Oncology +8

Survival Impact of Locoregional Treatment of the Primary Tumor in De Novo Metastatic Breast Cancers in a Large Multicentric Cohort Study: A Propensity Score-Matched Analysis

Elvire Pons‐Tostivint, Youlia Kirova, Amélie Lusque et al. · Annals of Surgical Oncology · 2018 · 54 citations

Breast Oncology, Oncology, Cancer Epidemiology +8

Is Regional Lymph Node Irradiation Necessary in Stage II to III Breast Cancer Patients With Negative Pathologic Node Status After Neoadjuvant Chemotherapy?

C. Daveau, Denise Stevens, Étienne Brain et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 43 citations

Breast Oncology, Stage Ii, Radiation Therapy +7